ONTOLOGY REPORT - ANNOTATIONS
| Term: | dichlorine |
|
| Accession: | CHEBI:29310
|
browse the term
|
| Definition: | A diatomic chlorine that has formula Cl2. |
| Synonyms: | related_synonym: | Cl2; ClCl; InChI=1S/Cl2/c1-2; InChIKey=KZBUYRJDOAKODT-UHFFFAOYSA-N; chlorine; molecular chlorine |
| | xref_casrn: | 7782-50-5 |
| | xref: | Beilstein:3902968 "Beilstein Registry Number"; ChemIDplus:7782-50-5 "CAS Registry Number"; Gmelin:788 "Gmelin Registry Number" |
| | xref_mesh: | MESH:D002713 |
| | xref: | NIST Chemistry WebBook:7782-50-5 "CAS Registry Number" |
|
|
dichlorine
|
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
multiple interactions |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcb1b |
ATP-binding cassette, subfamily B (MDR/TAP), member 1B |
|
increases expression |
EXP |
4 |
21,829,489 |
21,912,239 |
RGD:6480464 |
CTD |
| G |
Abcc1 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 1 |
|
multiple interactions |
EXP |
10 |
452,239 |
575,705 |
RGD:6480464 |
CTD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
multiple interactions |
EXP |
2 |
251,866,645 |
251,890,729 |
RGD:6480464 |
CTD |
| G |
Acot7 |
acyl-CoA thioesterase 7 |
|
multiple interactions |
EXP |
5 |
169,409,306 |
169,501,907 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
decreases expression |
EXP |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acsl1 |
acyl-CoA synthetase long-chain family member 1 |
|
multiple interactions |
EXP |
16 |
49,036,892 |
49,081,416 |
RGD:6480464 |
CTD |
| G |
Acvr1 |
activin A receptor, type I |
|
multiple interactions |
EXP |
3 |
40,191,727 |
40,260,488 |
RGD:6480464 |
CTD |
| G |
Adcy2 |
adenylate cyclase 2 (brain) |
|
multiple interactions |
EXP |
17 |
4,543,466 |
5,040,433 |
RGD:6480464 |
CTD |
| G |
Adcy3 |
adenylate cyclase 3 |
|
multiple interactions |
EXP |
6 |
27,118,325 |
27,202,275 |
RGD:6480464 |
CTD |
| G |
Adcy4 |
adenylate cyclase 4 |
|
multiple interactions |
EXP |
15 |
33,930,531 |
33,946,352 |
RGD:6480464 |
CTD |
| G |
Adcy5 |
adenylate cyclase 5 |
|
multiple interactions |
EXP |
11 |
67,290,968 |
67,437,468 |
RGD:6480464 |
CTD |
| G |
Adcy8 |
adenylate cyclase 8 (brain) |
|
multiple interactions |
EXP |
7 |
101,957,807 |
102,210,346 |
RGD:6480464 |
CTD |
| G |
Adora3 |
adenosine A3 receptor |
|
multiple interactions |
EXP |
2 |
201,157,782 |
201,161,425 |
RGD:6480464 |
CTD |
| G |
Adra2c |
adrenoceptor alpha 2C |
|
multiple interactions |
EXP |
14 |
81,107,907 |
81,109,610 |
RGD:6480464 |
CTD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
multiple interactions |
EXP |
18 |
58,174,958 |
58,177,000 |
RGD:6480464 |
CTD |
| G |
Adrbk2 |
adrenergic, beta, receptor kinase 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Adrbk2 |
adrenergic, beta, receptor kinase 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
decreases expression |
EXP |
20 |
4,250,613 |
4,253,540 |
RGD:6480464 |
CTD |
| G |
Ager |
advanced glycosylation end product-specific receptor |
|
multiple interactions |
EXP |
20 |
4,250,613 |
4,253,540 |
RGD:6480464 |
CTD |
| G |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
increases expression |
EXP |
5 |
136,920,561 |
136,937,422 |
RGD:6480464 |
CTD |
| G |
Akr1a1 |
aldo-keto reductase family 1, member A1 (aldehyde reductase) |
|
multiple interactions |
EXP |
5 |
136,920,561 |
136,937,422 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
multiple interactions |
EXP |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
multiple interactions |
EXP |
1 |
82,686,233 |
82,726,544 |
RGD:6480464 |
CTD |
| G |
Aldoc |
aldolase C, fructose-bisphosphate |
|
multiple interactions |
EXP |
10 |
64,308,826 |
64,312,415 |
RGD:6480464 |
CTD |
| G |
Amacr |
alpha-methylacyl-CoA racemase |
|
increases expression |
EXP |
2 |
60,332,292 |
60,344,326 |
RGD:6480464 |
CTD |
| G |
Amacr |
alpha-methylacyl-CoA racemase |
|
multiple interactions |
EXP |
2 |
60,332,292 |
60,344,326 |
RGD:6480464 |
CTD |
| G |
Amph |
amphiphysin |
|
multiple interactions |
EXP |
17 |
53,558,804 |
53,802,936 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
multiple interactions |
EXP |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa2 |
annexin A2 |
|
increases expression |
EXP |
8 |
73,897,618 |
73,934,041 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
increases expression |
EXP |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
multiple interactions |
EXP |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Anxa4 |
annexin A4 |
|
multiple interactions |
EXP |
4 |
120,889,617 |
120,947,662 |
RGD:6480464 |
CTD |
| G |
Anxa5 |
annexin A5 |
|
multiple interactions |
EXP |
2 |
122,949,210 |
122,979,757 |
RGD:6480464 |
CTD |
| G |
Apc |
adenomatous polyposis coli |
|
multiple interactions |
EXP |
18 |
26,732,147 |
26,790,383 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
multiple interactions |
EXP |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Apod |
apolipoprotein D |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Aqp1 |
aquaporin 1 |
|
multiple interactions |
EXP |
4 |
84,098,346 |
84,110,524 |
RGD:6480464 |
CTD |
| G |
Aqp3 |
aquaporin 3 |
|
decreases expression |
EXP |
5 |
58,501,642 |
58,507,159 |
RGD:6480464 |
CTD |
| G |
Aqp3 |
aquaporin 3 |
|
multiple interactions |
EXP |
5 |
58,501,642 |
58,507,159 |
RGD:6480464 |
CTD |
| G |
Arf1 |
ADP-ribosylation factor 1 |
|
multiple interactions |
EXP |
10 |
45,516,609 |
45,532,091 |
RGD:6480464 |
CTD |
| G |
Arf3 |
ADP-ribosylation factor 3 |
|
multiple interactions |
EXP |
7 |
137,505,200 |
137,510,262 |
RGD:6480464 |
CTD |
| G |
Arf4 |
ADP-ribosylation factor 4 |
|
multiple interactions |
EXP |
16 |
1,955,745 |
1,972,321 |
RGD:6480464 |
CTD |
| G |
Arf5 |
ADP-ribosylation factor 5 |
|
increases expression |
EXP |
4 |
55,293,825 |
55,296,751 |
RGD:6480464 |
CTD |
| G |
Arf5 |
ADP-ribosylation factor 5 |
|
multiple interactions |
EXP |
4 |
55,293,825 |
55,296,751 |
RGD:6480464 |
CTD |
| G |
Arf6 |
ADP-ribosylation factor 6 |
|
increases expression |
EXP |
6 |
91,337,496 |
91,338,644 |
RGD:6480464 |
CTD |
| G |
Arf6 |
ADP-ribosylation factor 6 |
|
multiple interactions |
EXP |
6 |
91,337,496 |
91,338,644 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
multiple interactions |
EXP |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arhgap35 |
Rho GTPase activating protein 35 |
|
decreases expression |
EXP |
1 |
76,757,031 |
76,824,155 |
RGD:6480464 |
CTD |
| G |
Arhgap35 |
Rho GTPase activating protein 35 |
|
multiple interactions |
EXP |
1 |
76,757,031 |
76,824,155 |
RGD:6480464 |
CTD |
| G |
Arrb2 |
arrestin, beta 2 |
|
multiple interactions |
EXP |
10 |
57,244,071 |
57,284,166 |
RGD:6480464 |
CTD |
| G |
Atf2 |
activating transcription factor 2 |
|
multiple interactions |
EXP |
3 |
56,403,676 |
56,496,473 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
multiple interactions |
EXP |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
decreases expression |
EXP |
2 |
196,657,749 |
196,687,242 |
RGD:6480464 |
CTD |
| G |
Atp2a3 |
ATPase, Ca++ transporting, ubiquitous |
|
decreases expression |
EXP |
10 |
59,853,363 |
59,884,087 |
RGD:6480464 |
CTD |
| G |
Atp2a3 |
ATPase, Ca++ transporting, ubiquitous |
|
multiple interactions |
EXP |
10 |
59,853,363 |
59,884,087 |
RGD:6480464 |
CTD |
| G |
Atp6v0c |
ATPase, H+ transporting, lysosomal V0 subunit C |
|
multiple interactions |
EXP |
10 |
13,415,671 |
13,420,715 |
RGD:6480464 |
CTD |
| G |
Atp7b |
ATPase, Cu++ transporting, beta polypeptide |
|
multiple interactions |
EXP |
16 |
74,607,988 |
74,680,080 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
multiple interactions |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bdkrb2 |
bradykinin receptor B2 |
|
multiple interactions |
EXP |
6 |
129,744,781 |
129,748,851 |
RGD:6480464 |
CTD |
| G |
Bmp4 |
bone morphogenetic protein 4 |
|
multiple interactions |
EXP |
15 |
22,283,171 |
22,286,757 |
RGD:6480464 |
CTD |
| G |
C5ar1 |
complement component 5a receptor 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cacna1a |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
|
multiple interactions |
EXP |
19 |
25,188,170 |
25,424,495 |
RGD:6480464 |
CTD |
| G |
Cacna1b |
calcium channel, voltage-dependent, N type, alpha 1B subunit |
|
multiple interactions |
EXP |
3 |
2,842,948 |
3,039,747 |
RGD:6480464 |
CTD |
| G |
Cacnb3 |
calcium channel, voltage-dependent, beta 3 subunit |
|
multiple interactions |
EXP |
7 |
137,384,752 |
137,394,283 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
decreases expression |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Car3 |
carbonic anhydrase 3 |
|
multiple interactions |
EXP |
2 |
88,106,727 |
88,114,686 |
RGD:6480464 |
CTD |
| G |
Cartpt |
CART prepropeptide |
|
decreases expression |
EXP |
2 |
30,889,817 |
30,891,837 |
RGD:6480464 |
CTD |
| G |
Cartpt |
CART prepropeptide |
|
multiple interactions |
EXP |
2 |
30,889,817 |
30,891,837 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
multiple interactions |
EXP |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casr |
calcium-sensing receptor |
|
multiple interactions |
EXP |
11 |
66,084,169 |
66,153,292 |
RGD:6480464 |
CTD |
| G |
Cast |
calpastatin |
|
increases expression |
EXP |
2 |
1,495,048 |
1,608,477 |
RGD:6480464 |
CTD |
| G |
Cast |
calpastatin |
|
multiple interactions |
EXP |
2 |
1,495,048 |
1,608,477 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
decreases expression |
EXP |
1 |
163,156,914 |
163,166,969 |
RGD:6480464 |
CTD |
| G |
Cckbr |
cholecystokinin B receptor |
|
multiple interactions |
EXP |
1 |
163,156,914 |
163,166,969 |
RGD:6480464 |
CTD |
| G |
Ccl11 |
chemokine (C-C motif) ligand 11 |
|
increases expression |
ISO |
10 |
70,279,161 |
70,283,762 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl3 |
chemokine (C-C motif) ligand 3 |
|
increases expression |
ISO |
10 |
71,744,559 |
71,746,109 |
RGD:6480464 |
CTD |
| G |
Ccl5 |
chemokine (C-C motif) ligand 5 |
|
increases expression |
ISO |
10 |
71,605,791 |
71,610,330 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
multiple interactions |
EXP |
5 |
36,465,490 |
36,483,538 |
RGD:6480464 |
CTD |
| G |
Ccnc |
cyclin C |
|
increases expression |
EXP |
5 |
36,465,490 |
36,483,538 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
multiple interactions |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd3 |
cyclin D3 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
multiple interactions |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Cd4 |
Cd4 molecule |
|
decreases expression |
EXP |
4 |
160,988,512 |
161,014,038 |
RGD:6480464 |
CTD |
| G |
Cd4 |
Cd4 molecule |
|
multiple interactions |
EXP |
4 |
160,988,512 |
161,014,038 |
RGD:6480464 |
CTD |
| G |
Cd44 |
Cd44 molecule |
|
multiple interactions |
EXP |
3 |
88,022,962 |
88,110,352 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
multiple interactions |
EXP |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cdc25b |
cell division cycle 25B |
|
multiple interactions |
EXP |
3 |
118,893,716 |
118,903,516 |
RGD:6480464 |
CTD |
| G |
Cdh22 |
cadherin 22 |
|
multiple interactions |
EXP |
3 |
156,155,004 |
156,275,540 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
multiple interactions |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn2b |
cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) |
|
multiple interactions |
EXP |
5 |
108,939,669 |
108,945,293 |
RGD:6480464 |
CTD |
| G |
Cfl1 |
cofilin 1, non-muscle |
|
multiple interactions |
EXP |
1 |
208,133,876 |
208,137,408 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
multiple interactions |
EXP |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
increases transport |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Chrna1 |
cholinergic receptor, nicotinic, alpha 1 (muscle) |
|
increases expression |
EXP |
3 |
56,087,754 |
56,102,821 |
RGD:6480464 |
CTD |
| G |
Chrna1 |
cholinergic receptor, nicotinic, alpha 1 (muscle) |
|
multiple interactions |
EXP |
3 |
56,087,754 |
56,102,821 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
multiple interactions |
EXP |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Chrnb1 |
cholinergic receptor, nicotinic, beta 1 (muscle) |
|
multiple interactions |
EXP |
10 |
56,604,907 |
56,617,423 |
RGD:6480464 |
CTD |
| G |
Ckmt1b |
creatine kinase, mitochondrial 1B |
|
affects expression |
EXP |
3 |
108,158,887 |
108,163,888 |
RGD:6480464 |
CTD |
| G |
Ckmt1b |
creatine kinase, mitochondrial 1B |
|
multiple interactions |
EXP |
3 |
108,158,887 |
108,163,888 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
multiple interactions |
EXP |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Cmklr1 |
chemokine-like receptor 1 |
|
multiple interactions |
EXP |
12 |
44,056,527 |
44,061,043 |
RGD:6480464 |
CTD |
| G |
Cnn3 |
calponin 3, acidic |
|
multiple interactions |
EXP |
2 |
218,044,803 |
218,075,914 |
RGD:6480464 |
CTD |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
multiple interactions |
EXP |
5 |
50,427,173 |
50,445,471 |
RGD:6480464 |
CTD |
| G |
Cpd |
carboxypeptidase D |
|
multiple interactions |
EXP |
10 |
67,327,272 |
67,390,836 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
multiple interactions |
EXP |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Cpt1b |
carnitine palmitoyltransferase 1b, muscle |
|
increases expression |
EXP |
7 |
127,737,129 |
127,746,179 |
RGD:6480464 |
CTD |
| G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
increases expression |
EXP |
4 |
83,839,822 |
83,867,017 |
RGD:6480464 |
CTD |
| G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
multiple interactions |
EXP |
4 |
83,839,822 |
83,867,017 |
RGD:6480464 |
CTD |
| G |
Crk |
v-crk sarcoma virus CT10 oncogene homolog (avian) |
|
multiple interactions |
EXP |
10 |
63,017,662 |
63,040,420 |
RGD:6480464 |
CTD |
| G |
Csf1r |
colony stimulating factor 1 receptor |
|
multiple interactions |
EXP |
18 |
57,080,324 |
57,107,295 |
RGD:6480464 |
CTD |
| G |
Csf2 |
colony stimulating factor 2 (granulocyte-macrophage) |
|
increases expression |
ISO |
10 |
39,665,850 |
39,667,831 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
increases expression |
EXP |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
multiple interactions |
EXP |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csf3 |
colony stimulating factor 3 (granulocyte) |
|
increases expression |
ISO |
10 |
87,473,990 |
87,476,365 |
RGD:6480464 |
CTD |
| G |
Csnk1g1 |
casein kinase 1, gamma 1 |
|
multiple interactions |
EXP |
8 |
70,193,231 |
70,301,592 |
RGD:6480464 |
CTD |
| G |
Csnk1g1 |
casein kinase 1, gamma 1 |
|
decreases expression |
EXP |
8 |
70,193,231 |
70,301,592 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
increases expression |
EXP |
1 |
98,601,681 |
98,611,747 |
RGD:6480464 |
CTD |
| G |
Csrp3 |
cysteine and glycine-rich protein 3 (cardiac LIM protein) |
|
multiple interactions |
EXP |
1 |
98,601,681 |
98,611,747 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
multiple interactions |
EXP |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
multiple interactions |
EXP |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
multiple interactions |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl1 |
chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) |
|
increases expression |
ISO |
14 |
18,690,339 |
18,692,118 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
decreases expression |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
multiple interactions |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcr4 |
chemokine (C-X-C motif) receptor 4 |
|
multiple interactions |
EXP |
13 |
41,308,286 |
41,312,190 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp2c23 |
cytochrome P450, family 2, subfamily c, polypeptide 23 |
|
decreases expression |
EXP |
1 |
249,204,049 |
249,228,689 |
RGD:6480464 |
CTD |
| G |
Cyp2c23 |
cytochrome P450, family 2, subfamily c, polypeptide 23 |
|
multiple interactions |
EXP |
1 |
249,204,049 |
249,228,689 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
decreases expression |
EXP |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4a3 |
cytochrome P450, family 4, subfamily a, polypeptide 3 |
|
multiple interactions |
EXP |
5 |
135,876,140 |
135,893,753 |
RGD:6480464 |
CTD |
| G |
Cyp4f4 |
cytochrome P450, family 4, subfamily f, polypeptide 4 |
|
decreases expression |
EXP |
7 |
13,293,080 |
13,309,416 |
RGD:6480464 |
CTD |
| G |
Cyp4f4 |
cytochrome P450, family 4, subfamily f, polypeptide 4 |
|
multiple interactions |
EXP |
7 |
13,293,080 |
13,309,416 |
RGD:6480464 |
CTD |
| G |
Ddc |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
|
multiple interactions |
EXP |
14 |
92,698,636 |
92,788,635 |
RGD:6480464 |
CTD |
| G |
Ddc |
dopa decarboxylase (aromatic L-amino acid decarboxylase) |
|
decreases expression |
EXP |
14 |
92,698,636 |
92,788,635 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
multiple interactions |
EXP |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Dpp4 |
dipeptidylpeptidase 4 |
|
multiple interactions |
EXP |
3 |
44,279,255 |
44,360,283 |
RGD:6480464 |
CTD |
| G |
Dpp6 |
dipeptidylpeptidase 6 |
|
multiple interactions |
EXP |
4 |
2,853,479 |
3,565,666 |
RGD:6480464 |
CTD |
| G |
Drd1 |
dopamine receptor D1 |
|
multiple interactions |
EXP |
17 |
16,655,926 |
16,658,161 |
RGD:6480464 |
CTD |
| G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
multiple interactions |
EXP |
7 |
10,017,061 |
10,022,331 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
multiple interactions |
EXP |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Eif2s1 |
eukaryotic translation initiation factor 2, subunit 1 alpha |
|
multiple interactions |
EXP |
6 |
101,495,444 |
101,520,113 |
RGD:6480464 |
CTD |
| G |
Eif5 |
eukaryotic translation initiation factor 5 |
|
multiple interactions |
EXP |
6 |
136,311,381 |
136,318,586 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
decreases expression |
EXP |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
F2 |
coagulation factor II |
|
multiple interactions |
EXP |
3 |
76,005,318 |
76,018,603 |
RGD:6480464 |
CTD |
| G |
Faah |
fatty acid amide hydrolase |
|
multiple interactions |
EXP |
5 |
136,310,965 |
136,329,817 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
decreases expression |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
multiple interactions |
EXP |
4 |
104,412,200 |
104,415,981 |
RGD:6480464 |
CTD |
| G |
Fabp2 |
fatty acid binding protein 2, intestinal |
|
multiple interactions |
EXP |
2 |
219,591,502 |
219,605,097 |
RGD:6480464 |
CTD |
| G |
Fabp4 |
fatty acid binding protein 4, adipocyte |
|
multiple interactions |
EXP |
2 |
93,536,133 |
93,540,734 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
decreases expression |
EXP |
2 |
50,866,799 |
50,940,319 |
RGD:6480464 |
CTD |
| G |
Fgf10 |
fibroblast growth factor 10 |
|
multiple interactions |
EXP |
2 |
50,866,799 |
50,940,319 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
multiple interactions |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
decreases expression |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgr |
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
multiple interactions |
EXP |
5 |
152,119,455 |
152,147,057 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
multiple interactions |
EXP |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor 1 |
|
decreases expression |
EXP |
20 |
1,553,297 |
1,582,426 |
RGD:6480464 |
CTD |
| G |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor 1 |
|
multiple interactions |
EXP |
20 |
1,553,297 |
1,582,426 |
RGD:6480464 |
CTD |
| G |
Galr1 |
galanin receptor 1 |
|
decreases expression |
EXP |
18 |
78,858,892 |
78,874,451 |
RGD:6480464 |
CTD |
| G |
Galr1 |
galanin receptor 1 |
|
multiple interactions |
EXP |
18 |
78,858,892 |
78,874,451 |
RGD:6480464 |
CTD |
| G |
Gapdh |
glyceraldehyde-3-phosphate dehydrogenase |
|
multiple interactions |
EXP |
4 |
161,282,215 |
161,286,090 |
RGD:6480464 |
CTD |
| G |
Gcgr |
glucagon receptor |
|
multiple interactions |
EXP |
10 |
109,921,411 |
109,929,577 |
RGD:6480464 |
CTD |
| G |
Gclm |
glutamate cysteine ligase, modifier subunit |
|
multiple interactions |
EXP |
2 |
218,895,434 |
218,915,491 |
RGD:6480464 |
CTD |
| G |
Gdi1 |
GDP dissociation inhibitor 1 |
|
multiple interactions |
EXP |
X |
160,299,115 |
160,305,777 |
RGD:6480464 |
CTD |
| G |
Gdi2 |
GDP dissociation inhibitor 2 |
|
multiple interactions |
EXP |
17 |
77,843,481 |
77,870,171 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
multiple interactions |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Ghr |
growth hormone receptor |
|
decreases expression |
EXP |
2 |
52,496,517 |
52,658,066 |
RGD:6480464 |
CTD |
| G |
Gipr |
gastric inhibitory polypeptide receptor |
|
multiple interactions |
EXP |
1 |
78,515,051 |
78,526,160 |
RGD:6480464 |
CTD |
| G |
Gmfb |
glia maturation factor, beta |
|
multiple interactions |
EXP |
15 |
22,664,728 |
22,675,100 |
RGD:6480464 |
CTD |
| G |
Gnai1 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1 |
|
multiple interactions |
EXP |
4 |
12,465,089 |
12,495,028 |
RGD:6480464 |
CTD |
| G |
Gnai2 |
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 |
|
multiple interactions |
EXP |
8 |
112,861,952 |
112,882,647 |
RGD:6480464 |
CTD |
| G |
Gnao1 |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
|
decreases expression |
EXP |
19 |
11,472,083 |
11,623,600 |
RGD:6480464 |
CTD |
| G |
Gnao1 |
guanine nucleotide binding protein (G protein), alpha activating activity polypeptide O |
|
multiple interactions |
EXP |
19 |
11,472,083 |
11,623,600 |
RGD:6480464 |
CTD |
| G |
Gnas |
GNAS complex locus |
|
multiple interactions |
EXP |
3 |
165,213,399 |
165,214,551 |
RGD:6480464 |
CTD |
| G |
Gnaz |
guanine nucleotide binding protein (G protein), alpha z polypeptide |
|
increases expression |
EXP |
20 |
14,148,003 |
14,174,136 |
RGD:6480464 |
CTD |
| G |
Gnaz |
guanine nucleotide binding protein (G protein), alpha z polypeptide |
|
multiple interactions |
EXP |
20 |
14,148,003 |
14,174,136 |
RGD:6480464 |
CTD |
| G |
Gnb1 |
guanine nucleotide binding protein (G protein), beta polypeptide 1 |
|
multiple interactions |
EXP |
5 |
172,341,135 |
172,386,772 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
increases expression |
EXP |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx3 |
glutathione peroxidase 3 |
|
multiple interactions |
EXP |
10 |
40,311,094 |
40,319,382 |
RGD:6480464 |
CTD |
| G |
Gpx5 |
glutathione peroxidase 5 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gpx5 |
glutathione peroxidase 5 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
multiple interactions |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
multiple interactions |
EXP |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
increases expression |
EXP |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
decreases expression |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gsta4 |
glutathione S-transferase alpha 4 |
|
multiple interactions |
EXP |
8 |
83,165,139 |
83,183,055 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
increases expression |
EXP |
4 |
69,999,767 |
70,004,086 |
RGD:6480464 |
CTD |
| G |
Gstk1 |
glutathione S-transferase kappa 1 |
|
multiple interactions |
EXP |
4 |
69,999,767 |
70,004,086 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
decreases expression |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstm2 |
glutathione S-transferase mu 2 |
|
multiple interactions |
EXP |
2 |
203,549,022 |
203,553,380 |
RGD:6480464 |
CTD |
| G |
Gstt2 |
glutathione S-transferase, theta 2 |
|
multiple interactions |
EXP |
20 |
13,221,696 |
13,225,367 |
RGD:6480464 |
CTD |
| G |
Gucy2d |
guanylate cyclase 2D, membrane (retina-specific) |
|
multiple interactions |
EXP |
10 |
56,012,236 |
56,027,290 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
decreases expression |
EXP |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hmgcs2 |
3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) |
|
multiple interactions |
EXP |
2 |
193,128,736 |
193,143,106 |
RGD:6480464 |
CTD |
| G |
Hpcal4 |
hippocalcin-like 4 |
|
multiple interactions |
EXP |
5 |
142,490,462 |
142,498,359 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
increases expression |
EXP |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hprt1 |
hypoxanthine phosphoribosyltransferase 1 |
|
multiple interactions |
EXP |
X |
139,929,647 |
139,961,616 |
RGD:6480464 |
CTD |
| G |
Hras |
Harvey rat sarcoma virus oncogene |
|
multiple interactions |
EXP |
1 |
201,385,705 |
201,388,987 |
RGD:6480464 |
CTD |
| G |
Hsd3b |
3 beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase type II |
|
decreases expression |
EXP |
2 |
193,387,391 |
193,388,559 |
RGD:6480464 |
CTD |
| G |
Hsd3b |
3 beta-hydroxysteroid dehydrogenase/delta-5-delta-4 isomerase type II |
|
multiple interactions |
EXP |
2 |
193,387,391 |
193,388,559 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
multiple interactions |
EXP |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
decreases expression |
EXP |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Hspa5 |
heat shock protein 5 |
|
multiple interactions |
EXP |
3 |
13,783,825 |
13,788,022 |
RGD:6480464 |
CTD |
| G |
Hspd1 |
heat shock protein 1 (chaperonin) |
|
multiple interactions |
EXP |
9 |
53,884,193 |
53,895,043 |
RGD:6480464 |
CTD |
| G |
Htr1f |
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
|
multiple interactions |
EXP |
11 |
2,260,587 |
2,261,687 |
RGD:6480464 |
CTD |
| G |
Htr6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
multiple interactions |
EXP |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Id2 |
inhibitor of DNA binding 2 |
|
decreases expression |
EXP |
6 |
42,781,476 |
42,783,307 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
multiple interactions |
EXP |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
increases expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igfals |
insulin-like growth factor binding protein, acid labile subunit |
|
multiple interactions |
EXP |
10 |
14,127,416 |
14,130,662 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
decreases expression |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
multiple interactions |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Il12a |
interleukin 12A |
|
increases expression |
ISO |
2 |
158,710,261 |
158,717,689 |
RGD:6480464 |
CTD |
| G |
Il12b |
interleukin 12B |
|
increases expression |
ISO |
10 |
29,558,955 |
29,568,331 |
RGD:6480464 |
CTD |
| G |
Il13 |
interleukin 13 |
|
increases expression |
ISO |
10 |
39,093,512 |
39,096,069 |
RGD:6480464 |
CTD |
| G |
Il18 |
interleukin 18 |
|
multiple interactions |
EXP |
8 |
53,936,584 |
53,943,228 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
multiple interactions |
EXP |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1b |
interleukin 1 beta |
|
increases expression |
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:6480464 |
CTD |
| G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
multiple interactions |
EXP |
9 |
39,577,879 |
39,624,781 |
RGD:6480464 |
CTD |
| G |
Il1rl1 |
interleukin 1 receptor-like 1 |
|
decreases expression |
EXP |
9 |
39,577,879 |
39,624,781 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
multiple interactions |
EXP |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Insrr |
insulin receptor-related receptor |
|
multiple interactions |
EXP |
2 |
179,857,189 |
179,876,572 |
RGD:6480464 |
CTD |
| G |
Itga1 |
integrin, alpha 1 |
|
multiple interactions |
EXP |
2 |
47,107,849 |
47,206,261 |
RGD:6480464 |
CTD |
| G |
Itgb1 |
integrin, beta 1 |
|
multiple interactions |
EXP |
19 |
58,600,095 |
58,647,531 |
RGD:6480464 |
CTD |
| G |
Itpr3 |
inositol 1,4,5-trisphosphate receptor, type 3 |
|
multiple interactions |
EXP |
20 |
5,292,430 |
5,357,502 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
multiple interactions |
EXP |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Jup |
junction plakoglobin |
|
increases expression |
EXP |
10 |
89,307,938 |
89,335,254 |
RGD:6480464 |
CTD |
| G |
Jup |
junction plakoglobin |
|
multiple interactions |
EXP |
10 |
89,307,938 |
89,335,254 |
RGD:6480464 |
CTD |
| G |
Kcna4 |
potassium voltage-gated channel, shaker-related subfamily, member 4 |
|
multiple interactions |
EXP |
3 |
92,781,795 |
92,784,921 |
RGD:6480464 |
CTD |
| G |
Kcnb1 |
potassium voltage gated channel, Shab-related subfamily, member 1 |
|
affects expression |
EXP |
3 |
158,250,001 |
158,345,927 |
RGD:6480464 |
CTD |
| G |
Kcnb1 |
potassium voltage gated channel, Shab-related subfamily, member 1 |
|
multiple interactions |
EXP |
3 |
158,250,001 |
158,345,927 |
RGD:6480464 |
CTD |
| G |
Kcnd2 |
potassium voltage-gated channel, Shal-related subfamily, member 2 |
|
multiple interactions |
EXP |
4 |
47,541,787 |
48,047,924 |
RGD:6480464 |
CTD |
| G |
Kcnj4 |
potassium inwardly-rectifying channel, subfamily J, member 4 |
|
decreases expression |
EXP |
7 |
117,601,723 |
117,616,019 |
RGD:6480464 |
CTD |
| G |
Kcnj4 |
potassium inwardly-rectifying channel, subfamily J, member 4 |
|
multiple interactions |
EXP |
7 |
117,601,723 |
117,616,019 |
RGD:6480464 |
CTD |
| G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
|
multiple interactions |
EXP |
8 |
32,082,866 |
32,104,412 |
RGD:6480464 |
CTD |
| G |
Kcnj8 |
potassium inwardly-rectifying channel, subfamily J, member 8 |
|
multiple interactions |
EXP |
4 |
180,144,084 |
180,149,935 |
RGD:6480464 |
CTD |
| G |
Klkb1 |
kallikrein B, plasma 1 |
|
multiple interactions |
EXP |
16 |
50,248,935 |
50,272,279 |
RGD:6480464 |
CTD |
| G |
Kras |
v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog |
|
multiple interactions |
EXP |
4 |
182,869,242 |
182,895,106 |
RGD:6480464 |
CTD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
multiple interactions |
EXP |
19 |
35,781,507 |
35,784,966 |
RGD:6480464 |
CTD |
| G |
Lcat |
lecithin cholesterol acyltransferase |
|
decreases expression |
EXP |
19 |
35,781,507 |
35,784,966 |
RGD:6480464 |
CTD |
| G |
Limk1 |
LIM domain kinase 1 |
|
multiple interactions |
EXP |
12 |
23,091,809 |
23,125,717 |
RGD:6480464 |
CTD |
| G |
Lipc |
lipase, hepatic |
|
decreases expression |
EXP |
8 |
75,323,442 |
75,450,353 |
RGD:6480464 |
CTD |
| G |
Lipc |
lipase, hepatic |
|
multiple interactions |
EXP |
8 |
75,323,442 |
75,450,353 |
RGD:6480464 |
CTD |
| G |
Lipe |
lipase, hormone sensitive |
|
multiple interactions |
EXP |
1 |
80,663,791 |
80,682,480 |
RGD:6480464 |
CTD |
| G |
Lphn1 |
latrophilin 1 |
|
decreases expression |
EXP |
19 |
25,891,157 |
25,931,128 |
RGD:6480464 |
CTD |
| G |
Lphn1 |
latrophilin 1 |
|
multiple interactions |
EXP |
19 |
25,891,157 |
25,931,128 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
multiple interactions |
EXP |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
increases expression |
EXP |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Mal |
mal, T-cell differentiation protein |
|
multiple interactions |
EXP |
3 |
115,166,671 |
115,190,432 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
multiple interactions |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
increases expression |
EXP |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Max |
MYC associated factor X |
|
multiple interactions |
EXP |
6 |
99,529,905 |
99,553,851 |
RGD:6480464 |
CTD |
| G |
Mc4r |
melanocortin 4 receptor |
|
multiple interactions |
EXP |
18 |
63,390,922 |
63,392,809 |
RGD:6480464 |
CTD |
| G |
Mcpt1 |
mast cell protease 1 |
|
increases expression |
EXP |
15 |
34,270,481 |
34,273,035 |
RGD:6480464 |
CTD |
| G |
Mcpt1 |
mast cell protease 1 |
|
multiple interactions |
EXP |
15 |
34,270,481 |
34,273,035 |
RGD:6480464 |
CTD |
| G |
Mecp2 |
methyl CpG binding protein 2 |
|
multiple interactions |
EXP |
X |
159,980,599 |
160,035,260 |
RGD:6480464 |
CTD |
| G |
Meox2 |
mesenchyme homeobox 2 |
|
affects expression |
EXP |
6 |
55,895,760 |
55,957,066 |
RGD:6480464 |
CTD |
| G |
Meox2 |
mesenchyme homeobox 2 |
|
multiple interactions |
EXP |
6 |
55,895,760 |
55,957,066 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
multiple interactions |
EXP |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
decreases expression |
EXP |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mgst1 |
microsomal glutathione S-transferase 1 |
|
multiple interactions |
EXP |
4 |
175,248,654 |
175,263,881 |
RGD:6480464 |
CTD |
| G |
Mmp14 |
matrix metallopeptidase 14 (membrane-inserted) |
|
multiple interactions |
EXP |
15 |
32,493,852 |
32,503,077 |
RGD:6480464 |
CTD |
| G |
Mrgprf |
MAS-related GPR, member F |
|
multiple interactions |
EXP |
1 |
205,750,528 |
205,759,996 |
RGD:6480464 |
CTD |
| G |
Mtnr1a |
melatonin receptor 1A |
|
decreases expression |
EXP |
16 |
50,439,407 |
50,458,585 |
RGD:6480464 |
CTD |
| G |
Mtnr1a |
melatonin receptor 1A |
|
multiple interactions |
EXP |
16 |
50,439,407 |
50,458,585 |
RGD:6480464 |
CTD |
| G |
Mvp |
major vault protein |
|
multiple interactions |
EXP |
1 |
186,164,811 |
186,192,802 |
RGD:6480464 |
CTD |
| G |
Mycs |
myc-like oncogene, s-myc protein |
|
multiple interactions |
EXP |
X |
28,062,010 |
28,063,302 |
RGD:6480464 |
CTD |
| G |
Myo1b |
myosin Ib |
|
increases expression |
EXP |
9 |
46,756,678 |
46,917,169 |
RGD:6480464 |
CTD |
| G |
Myo1b |
myosin Ib |
|
multiple interactions |
EXP |
9 |
46,756,678 |
46,917,169 |
RGD:6480464 |
CTD |
| G |
Nell1 |
NEL-like 1 (chicken) |
|
multiple interactions |
EXP |
1 |
99,805,922 |
100,758,002 |
RGD:6480464 |
CTD |
| G |
Nell2 |
NEL-like 2 (chicken) |
|
increases expression |
EXP |
7 |
133,758,271 |
134,080,104 |
RGD:6480464 |
CTD |
| G |
Nell2 |
NEL-like 2 (chicken) |
|
multiple interactions |
EXP |
7 |
133,758,271 |
134,080,104 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
multiple interactions |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
|
decreases expression |
EXP |
6 |
75,729,302 |
75,732,475 |
RGD:6480464 |
CTD |
| G |
Ngb |
neuroglobin |
|
affects abundance |
ISO |
6 |
111,231,188 |
111,236,255 |
RGD:6480464 |
CTD |
| G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
multiple interactions |
EXP |
10 |
82,582,766 |
82,588,269 |
RGD:6480464 |
CTD |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
multiple interactions |
EXP |
12 |
39,812,500 |
39,869,484 |
RGD:6480464 |
CTD |
| G |
Nos2 |
nitric oxide synthase 2, inducible |
|
increases expression |
EXP |
10 |
65,036,884 |
65,072,453 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases activity |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
decreases expression |
EXP |
4 |
6,158,847 |
6,179,441 |
RGD:6480464 |
CTD |
| G |
Nppc |
natriuretic peptide C |
|
multiple interactions |
EXP |
9 |
85,434,254 |
85,438,454 |
RGD:6480464 |
CTD |
| G |
Nppc |
natriuretic peptide C |
|
affects expression |
EXP |
9 |
85,434,254 |
85,438,454 |
RGD:6480464 |
CTD |
| G |
Nptxr |
neuronal pentraxin receptor |
|
multiple interactions |
EXP |
7 |
118,023,653 |
118,041,729 |
RGD:6480464 |
CTD |
| G |
Nr2c2 |
nuclear receptor subfamily 2, group C, member 2 |
|
decreases expression |
EXP |
4 |
126,319,412 |
126,344,808 |
RGD:6480464 |
CTD |
| G |
Nr2c2 |
nuclear receptor subfamily 2, group C, member 2 |
|
multiple interactions |
EXP |
4 |
126,319,412 |
126,344,808 |
RGD:6480464 |
CTD |
| G |
Nr2f1 |
nuclear receptor subfamily 2, group F, member 1 |
|
multiple interactions |
EXP |
2 |
5,765,399 |
5,794,104 |
RGD:6480464 |
CTD |
| G |
Nr3c2 |
nuclear receptor subfamily 3, group C, member 2 |
|
multiple interactions |
EXP |
19 |
32,527,752 |
32,875,369 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
decreases expression |
EXP |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr4a1 |
nuclear receptor subfamily 4, group A, member 1 |
|
multiple interactions |
EXP |
7 |
140,012,807 |
140,020,590 |
RGD:6480464 |
CTD |
| G |
Nr4a3 |
nuclear receptor subfamily 4, group A, member 3 |
|
multiple interactions |
EXP |
5 |
64,713,468 |
64,753,311 |
RGD:6480464 |
CTD |
| G |
Nrp2 |
neuropilin 2 |
|
multiple interactions |
EXP |
9 |
61,348,529 |
61,460,457 |
RGD:6480464 |
CTD |
| G |
Nrxn1 |
neurexin 1 |
|
multiple interactions |
EXP |
6 |
14,050,929 |
15,354,069 |
RGD:6480464 |
CTD |
| G |
Nrxn2 |
neurexin 2 |
|
multiple interactions |
EXP |
1 |
209,211,740 |
209,318,064 |
RGD:6480464 |
CTD |
| G |
Ntrk1 |
neurotrophic tyrosine kinase, receptor, type 1 |
|
multiple interactions |
EXP |
2 |
179,838,740 |
179,855,545 |
RGD:6480464 |
CTD |
| G |
Ntsr2 |
neurotensin receptor 2 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Ntsr2 |
neurotensin receptor 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
multiple interactions |
EXP |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Olr1172 |
olfactory receptor 1172 |
|
increases expression |
EXP |
8 |
18,628,573 |
18,629,568 |
RGD:6480464 |
CTD |
| G |
Olr1172 |
olfactory receptor 1172 |
|
multiple interactions |
EXP |
8 |
18,628,573 |
18,629,568 |
RGD:6480464 |
CTD |
| G |
Oprk1 |
opioid receptor, kappa 1 |
|
multiple interactions |
EXP |
5 |
14,040,848 |
14,055,273 |
RGD:6480464 |
CTD |
| G |
Oprk1 |
opioid receptor, kappa 1 |
|
decreases expression |
EXP |
5 |
14,040,848 |
14,055,273 |
RGD:6480464 |
CTD |
| G |
Pak1 |
p21 protein (Cdc42/Rac)-activated kinase 1 |
|
multiple interactions |
EXP |
1 |
155,057,622 |
155,174,714 |
RGD:6480464 |
CTD |
| G |
Pbsn |
probasin |
|
multiple interactions |
EXP |
X |
63,581,742 |
63,597,497 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcsk7 |
proprotein convertase subtilisin/kexin type 7 |
|
multiple interactions |
EXP |
8 |
48,879,382 |
48,901,968 |
RGD:6480464 |
CTD |
| G |
Pdap1 |
PDGFA associated protein 1 |
|
multiple interactions |
EXP |
12 |
9,784,744 |
9,794,971 |
RGD:6480464 |
CTD |
| G |
Pde4d |
phosphodiesterase 4D, cAMP-specific |
|
multiple interactions |
EXP |
2 |
40,196,097 |
41,311,012 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
multiple interactions |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
multiple interactions |
EXP |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
increases expression |
EXP |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pdlim1 |
PDZ and LIM domain 1 |
|
multiple interactions |
EXP |
1 |
245,350,086 |
245,399,534 |
RGD:6480464 |
CTD |
| G |
Pfkfb4 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 |
|
multiple interactions |
EXP |
8 |
114,012,543 |
114,050,534 |
RGD:6480464 |
CTD |
| G |
Pgap2 |
post-GPI attachment to proteins 2 |
|
multiple interactions |
EXP |
1 |
159,696,924 |
159,722,582 |
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Phb |
prohibitin |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Pi4ka |
phosphatidylinositol 4-kinase, catalytic, alpha |
|
decreases expression |
EXP |
11 |
85,610,281 |
85,726,603 |
RGD:6480464 |
CTD |
| G |
Pi4ka |
phosphatidylinositol 4-kinase, catalytic, alpha |
|
multiple interactions |
EXP |
11 |
85,610,281 |
85,726,603 |
RGD:6480464 |
CTD |
| G |
Pla2g2c |
phospholipase A2, group IIC |
|
multiple interactions |
EXP |
5 |
157,536,546 |
157,555,895 |
RGD:6480464 |
CTD |
| G |
Plat |
plasminogen activator, tissue |
|
multiple interactions |
EXP |
16 |
73,711,323 |
73,736,328 |
RGD:6480464 |
CTD |
| G |
Plec |
plectin |
|
multiple interactions |
EXP |
7 |
114,202,742 |
114,262,385 |
RGD:6480464 |
CTD |
| G |
Pmp22 |
peripheral myelin protein 22 |
|
multiple interactions |
EXP |
10 |
49,305,835 |
49,335,864 |
RGD:6480464 |
CTD |
| G |
Pnlip |
pancreatic lipase |
|
multiple interactions |
EXP |
1 |
265,107,812 |
265,120,969 |
RGD:6480464 |
CTD |
| G |
Ppap2a |
phosphatidic acid phosphatase type 2A |
|
multiple interactions |
EXP |
2 |
44,183,290 |
44,247,787 |
RGD:6480464 |
CTD |
| G |
Ppap2a |
phosphatidic acid phosphatase type 2A |
|
decreases expression |
EXP |
2 |
44,183,290 |
44,247,787 |
RGD:6480464 |
CTD |
| G |
Ppp2ca |
protein phosphatase 2, catalytic subunit, alpha isozyme |
|
multiple interactions |
EXP |
10 |
37,621,256 |
37,641,008 |
RGD:6480464 |
CTD |
| G |
Ppp2cb |
protein phosphatase 2, catalytic subunit, beta isozyme |
|
multiple interactions |
EXP |
16 |
62,330,513 |
62,351,968 |
RGD:6480464 |
CTD |
| G |
Prdx2 |
peroxiredoxin 2 |
|
multiple interactions |
EXP |
19 |
24,836,199 |
24,841,390 |
RGD:6480464 |
CTD |
| G |
Prmt1 |
protein arginine methyltransferase 1 |
|
multiple interactions |
EXP |
1 |
95,449,061 |
95,458,267 |
RGD:6480464 |
CTD |
| G |
Psma1 |
proteasome (prosome, macropain) subunit, alpha type 1 |
|
multiple interactions |
EXP |
1 |
172,237,763 |
172,248,782 |
RGD:6480464 |
CTD |
| G |
Psma2 |
proteasome (prosome, macropain) subunit, alpha type 2 |
|
multiple interactions |
EXP |
17 |
58,736,300 |
58,746,837 |
RGD:6480464 |
CTD |
| G |
Psma3l |
proteasome subunit alpha type 3-like |
|
increases expression |
EXP |
10 |
93,092,166 |
93,111,072 |
RGD:6480464 |
CTD |
| G |
Psma3l |
proteasome subunit alpha type 3-like |
|
multiple interactions |
EXP |
10 |
93,092,166 |
93,111,072 |
RGD:6480464 |
CTD |
| G |
Psma4 |
proteasome (prosome, macropain) subunit, alpha type 4 |
|
multiple interactions |
EXP |
8 |
58,508,643 |
58,516,103 |
RGD:6480464 |
CTD |
| G |
Psmb3 |
proteasome (prosome, macropain) subunit, beta type 3 |
|
multiple interactions |
EXP |
10 |
86,452,533 |
86,459,616 |
RGD:6480464 |
CTD |
| G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
|
increases expression |
EXP |
2 |
189,778,476 |
189,781,169 |
RGD:6480464 |
CTD |
| G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
|
multiple interactions |
EXP |
2 |
189,778,476 |
189,781,169 |
RGD:6480464 |
CTD |
| G |
Psmb6 |
proteasome (prosome, macropain) subunit, beta type 6 |
|
multiple interactions |
EXP |
10 |
57,370,397 |
57,372,704 |
RGD:6480464 |
CTD |
| G |
Psmb8 |
proteasome (prosome, macropain) subunit, beta type, 8 |
|
multiple interactions |
EXP |
20 |
4,786,260 |
4,789,223 |
RGD:6480464 |
CTD |
| G |
Psmc1 |
proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
|
multiple interactions |
EXP |
6 |
124,380,976 |
124,393,338 |
RGD:6480464 |
CTD |
| G |
Psmc2 |
proteasome (prosome, macropain) 26S subunit, ATPase 2 |
|
multiple interactions |
EXP |
4 |
8,704,100 |
8,718,351 |
RGD:6480464 |
CTD |
| G |
Psmc4 |
proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
|
multiple interactions |
EXP |
1 |
83,151,149 |
83,159,464 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
increases expression |
EXP |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
multiple interactions |
EXP |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Ptafr |
platelet-activating factor receptor |
|
increases expression |
EXP |
5 |
152,565,687 |
152,587,342 |
RGD:6480464 |
CTD |
| G |
Ptafr |
platelet-activating factor receptor |
|
multiple interactions |
EXP |
5 |
152,565,687 |
152,587,342 |
RGD:6480464 |
CTD |
| G |
Ptn |
pleiotrophin |
|
multiple interactions |
EXP |
4 |
64,078,755 |
64,160,135 |
RGD:6480464 |
CTD |
| G |
Ptn |
pleiotrophin |
|
increases expression |
EXP |
4 |
64,078,755 |
64,160,135 |
RGD:6480464 |
CTD |
| G |
Ptpn11 |
protein tyrosine phosphatase, non-receptor type 11 |
|
multiple interactions |
EXP |
12 |
36,501,886 |
36,558,055 |
RGD:6480464 |
CTD |
| G |
Ptpn7 |
protein tyrosine phosphatase, non-receptor type 7 |
|
multiple interactions |
EXP |
13 |
48,094,119 |
48,105,707 |
RGD:6480464 |
CTD |
| G |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
|
decreases expression |
EXP |
7 |
55,324,246 |
55,612,945 |
RGD:6480464 |
CTD |
| G |
Ptprr |
protein tyrosine phosphatase, receptor type, R |
|
multiple interactions |
EXP |
7 |
55,324,246 |
55,612,945 |
RGD:6480464 |
CTD |
| G |
Rab15 |
RAB15, member RAS oncogene family |
|
increases expression |
EXP |
6 |
99,378,937 |
99,403,340 |
RGD:6480464 |
CTD |
| G |
Rab15 |
RAB15, member RAS oncogene family |
|
multiple interactions |
EXP |
6 |
99,378,937 |
99,403,340 |
RGD:6480464 |
CTD |
| G |
Rab1a |
RAB1A, member RAS oncogene family |
|
multiple interactions |
EXP |
14 |
100,973,039 |
101,027,893 |
RGD:6480464 |
CTD |
| G |
Rab1a |
RAB1A, member RAS oncogene family |
|
increases expression |
EXP |
14 |
100,973,039 |
101,027,893 |
RGD:6480464 |
CTD |
| G |
Rab3b |
RAB3B, member RAS oncogene family |
|
multiple interactions |
EXP |
5 |
130,185,155 |
130,284,038 |
RGD:6480464 |
CTD |
| G |
Rab3d |
RAB3D, member RAS oncogene family |
|
multiple interactions |
EXP |
8 |
21,012,295 |
21,021,327 |
RGD:6480464 |
CTD |
| G |
Rab4a |
RAB4A, member RAS oncogene family |
|
multiple interactions |
EXP |
19 |
53,991,122 |
54,019,248 |
RGD:6480464 |
CTD |
| G |
Rala |
v-ral simian leukemia viral oncogene homolog A (ras related) |
|
multiple interactions |
EXP |
17 |
55,017,444 |
55,030,555 |
RGD:6480464 |
CTD |
| G |
Ralgds |
ral guanine nucleotide dissociation stimulator |
|
multiple interactions |
EXP |
3 |
7,516,054 |
7,537,651 |
RGD:6480464 |
CTD |
| G |
Ralgds |
ral guanine nucleotide dissociation stimulator |
|
increases expression |
EXP |
3 |
7,516,054 |
7,537,651 |
RGD:6480464 |
CTD |
| G |
Rasa1 |
RAS p21 protein activator (GTPase activating protein) 1 |
|
multiple interactions |
EXP |
2 |
14,203,815 |
14,287,824 |
RGD:6480464 |
CTD |
| G |
Rims1 |
regulating synaptic membrane exocytosis 1 |
|
multiple interactions |
EXP |
9 |
21,089,088 |
21,594,679 |
RGD:6480464 |
CTD |
| G |
Rin1 |
Ras and Rab interactor 1 |
|
multiple interactions |
EXP |
1 |
207,671,502 |
207,676,150 |
RGD:6480464 |
CTD |
| G |
Rnpep |
arginyl aminopeptidase (aminopeptidase B) |
|
multiple interactions |
EXP |
13 |
48,267,923 |
48,286,295 |
RGD:6480464 |
CTD |
| G |
Rpl10 |
ribosomal protein L10 |
|
multiple interactions |
EXP |
X |
160,336,632 |
160,338,842 |
RGD:6480464 |
CTD |
| G |
Rpl11 |
ribosomal protein L11 |
|
increases expression |
EXP |
5 |
154,826,973 |
154,830,183 |
RGD:6480464 |
CTD |
| G |
Rpl11 |
ribosomal protein L11 |
|
multiple interactions |
EXP |
5 |
154,826,973 |
154,830,183 |
RGD:6480464 |
CTD |
| G |
Rpl12 |
ribosomal protein L12 |
|
multiple interactions |
EXP |
3 |
11,951,921 |
11,954,295 |
RGD:6480464 |
CTD |
| G |
Rpl13 |
ribosomal protein L13 |
|
multiple interactions |
EXP |
19 |
53,437,633 |
53,440,184 |
RGD:6480464 |
CTD |
| G |
Rpl21 |
ribosomal protein L21 |
|
multiple interactions |
EXP |
12 |
8,716,675 |
8,719,754 |
RGD:6480464 |
CTD |
| G |
Rpl36al |
ribosomal protein L36a-like |
|
multiple interactions |
EXP |
6 |
91,135,710 |
91,137,104 |
RGD:6480464 |
CTD |
| G |
Rps11 |
ribosomal protein S11 |
|
multiple interactions |
EXP |
1 |
95,596,744 |
95,598,852 |
RGD:6480464 |
CTD |
| G |
Rps12 |
ribosomal protein S12 |
|
multiple interactions |
EXP |
1 |
22,265,326 |
22,267,482 |
RGD:6480464 |
CTD |
| G |
Rps17 |
ribosomal protein S17 |
|
multiple interactions |
EXP |
1 |
137,552,232 |
137,554,817 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
increases expression |
EXP |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
multiple interactions |
EXP |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps29 |
ribosomal protein S29 |
|
multiple interactions |
EXP |
6 |
91,115,709 |
91,117,085 |
RGD:6480464 |
CTD |
| G |
Rps4x |
ribosomal protein S4, X-linked |
|
increases expression |
EXP |
X |
34,793,683 |
34,794,576 |
RGD:6480464 |
CTD |
| G |
Rps4x |
ribosomal protein S4, X-linked |
|
multiple interactions |
EXP |
X |
34,793,683 |
34,794,576 |
RGD:6480464 |
CTD |
| G |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
|
decreases expression |
EXP |
8 |
19,989,867 |
20,000,759 |
RGD:6480464 |
CTD |
| G |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
|
multiple interactions |
EXP |
8 |
19,989,867 |
20,000,759 |
RGD:6480464 |
CTD |
| G |
Scn2b |
sodium channel, voltage-gated, type II, beta |
|
decreases expression |
EXP |
8 |
48,068,843 |
48,078,632 |
RGD:6480464 |
CTD |
| G |
Scn2b |
sodium channel, voltage-gated, type II, beta |
|
multiple interactions |
EXP |
8 |
48,068,843 |
48,078,632 |
RGD:6480464 |
CTD |
| G |
Scn4a |
sodium channel, voltage-gated, type IV, alpha subunit |
|
multiple interactions |
EXP |
10 |
95,710,710 |
95,760,323 |
RGD:6480464 |
CTD |
| G |
Scp2 |
sterol carrier protein 2 |
|
decreases expression |
EXP |
5 |
129,152,836 |
129,230,401 |
RGD:6480464 |
CTD |
| G |
Scp2 |
sterol carrier protein 2 |
|
multiple interactions |
EXP |
5 |
129,152,836 |
129,230,401 |
RGD:6480464 |
CTD |
| G |
Sctr |
secretin receptor |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Selp |
selectin P |
|
multiple interactions |
EXP |
13 |
79,886,614 |
79,922,180 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
|
multiple interactions |
EXP |
13 |
13,037,587 |
13,057,785 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
increases expression |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Serpine1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
|
multiple interactions |
EXP |
12 |
20,931,996 |
20,942,374 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
decreases expression |
EXP |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Sgk1 |
serum/glucocorticoid regulated kinase 1 |
|
multiple interactions |
EXP |
1 |
23,501,257 |
23,506,651 |
RGD:6480464 |
CTD |
| G |
Sirpa |
signal-regulatory protein alpha |
|
multiple interactions |
EXP |
3 |
117,210,116 |
117,247,840 |
RGD:6480464 |
CTD |
| G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
decreases expression |
EXP |
6 |
104,735,839 |
104,749,464 |
RGD:6480464 |
CTD |
| G |
Slc10a1 |
solute carrier family 10 (sodium/bile acid cotransporter family), member 1 |
|
multiple interactions |
EXP |
6 |
104,735,839 |
104,749,464 |
RGD:6480464 |
CTD |
| G |
Slc14a2 |
solute carrier family 14 (urea transporter), member 2 |
|
multiple interactions |
EXP |
18 |
75,071,416 |
75,499,738 |
RGD:6480464 |
CTD |
| G |
Slc15a1 |
solute carrier family 15 (oligopeptide transporter), member 1 |
|
multiple interactions |
EXP |
15 |
106,549,586 |
106,592,594 |
RGD:6480464 |
CTD |
| G |
Slc15a4 |
solute carrier family 15, member 4 |
|
multiple interactions |
EXP |
12 |
30,111,863 |
30,131,134 |
RGD:6480464 |
CTD |
| G |
Slc16a1 |
solute carrier family 16, member 1 (monocarboxylic acid transporter 1) |
|
multiple interactions |
EXP |
2 |
199,860,341 |
199,879,856 |
RGD:6480464 |
CTD |
| G |
Slc18a1 |
solute carrier family 18 (vesicular monoamine), member 1 |
|
multiple interactions |
EXP |
16 |
22,356,304 |
22,389,827 |
RGD:6480464 |
CTD |
| G |
Slc1a6 |
solute carrier family 1 (high affinity aspartate/glutamate transporter), member 6 |
|
multiple interactions |
EXP |
7 |
12,393,284 |
12,419,893 |
RGD:6480464 |
CTD |
| G |
Slc22a1 |
solute carrier family 22 (organic cation transporter), member 1 |
|
multiple interactions |
EXP |
1 |
42,351,239 |
42,378,295 |
RGD:6480464 |
CTD |
| G |
Slc22a12 |
solute carrier family 22 (organic anion/urate transporter), member 12 |
|
multiple interactions |
ISO |
1 |
209,320,804 |
209,327,918 |
RGD:6480464 |
CTD |
| G |
Slc22a2 |
solute carrier family 22 (organic cation transporter), member 2 |
|
multiple interactions |
EXP |
1 |
42,395,676 |
42,442,847 |
RGD:6480464 |
CTD |
| G |
Slc4a2 |
solute carrier family 4 (anion exchanger), member 2 |
|
multiple interactions |
EXP |
4 |
6,100,783 |
6,117,982 |
RGD:6480464 |
CTD |
| G |
Slc6a12 |
solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 |
|
multiple interactions |
EXP |
4 |
157,781,178 |
157,800,038 |
RGD:6480464 |
CTD |
| G |
Slc6a15 |
solute carrier family 6 (neutral amino acid transporter), member 15 |
|
multiple interactions |
EXP |
7 |
41,498,013 |
41,552,028 |
RGD:6480464 |
CTD |
| G |
Slc6a9 |
solute carrier family 6 (neurotransmitter transporter, glycine), member 9 |
|
multiple interactions |
EXP |
5 |
138,300,869 |
138,334,893 |
RGD:6480464 |
CTD |
| G |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
|
multiple interactions |
EXP |
12 |
7,230,519 |
7,253,858 |
RGD:6480464 |
CTD |
| G |
Slc9a2 |
solute carrier family 9, subfamily A (NHE2, cation proton antiporter 2), member 2 |
|
multiple interactions |
EXP |
9 |
39,832,184 |
39,916,242 |
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a1 |
solute carrier organic anion transporter family, member 1a1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Slco1a4 |
solute carrier organic anion transporter family, member 1a4 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Smad1 |
SMAD family member 1 |
|
multiple interactions |
EXP |
19 |
30,348,886 |
30,409,345 |
RGD:6480464 |
CTD |
| G |
Smn1 |
survival of motor neuron 1, telomeric |
|
multiple interactions |
EXP |
2 |
31,147,743 |
31,159,938 |
RGD:6480464 |
CTD |
| G |
Snap25 |
synaptosomal-associated protein 25 |
|
multiple interactions |
EXP |
3 |
124,806,637 |
124,894,653 |
RGD:6480464 |
CTD |
| G |
Spon1 |
spondin 1, extracellular matrix protein |
|
multiple interactions |
EXP |
1 |
171,700,495 |
172,020,808 |
RGD:6480464 |
CTD |
| G |
Ssrp1 |
structure specific recognition protein 1 |
|
multiple interactions |
EXP |
3 |
68,272,947 |
68,282,596 |
RGD:6480464 |
CTD |
| G |
Sst |
somatostatin |
|
multiple interactions |
EXP |
11 |
79,125,031 |
79,126,216 |
RGD:6480464 |
CTD |
| G |
Sstr3 |
somatostatin receptor 3 |
|
multiple interactions |
EXP |
7 |
116,495,750 |
116,502,948 |
RGD:6480464 |
CTD |
| G |
Stx1b |
syntaxin 1B |
|
multiple interactions |
EXP |
1 |
187,092,014 |
187,108,481 |
RGD:6480464 |
CTD |
| G |
Stx5 |
syntaxin 5 |
|
multiple interactions |
EXP |
1 |
211,409,653 |
211,426,725 |
RGD:6480464 |
CTD |
| G |
Stx6 |
syntaxin 6 |
|
multiple interactions |
EXP |
13 |
70,121,864 |
70,169,379 |
RGD:6480464 |
CTD |
| G |
Sult1b1 |
sulfotransferase family, cytosolic, 1B, member 1 |
|
multiple interactions |
EXP |
14 |
22,019,193 |
22,031,914 |
RGD:6480464 |
CTD |
| G |
Sult1b1 |
sulfotransferase family, cytosolic, 1B, member 1 |
|
decreases expression |
EXP |
14 |
22,019,193 |
22,031,914 |
RGD:6480464 |
CTD |
| G |
Sv2b |
synaptic vesicle glycoprotein 2b |
|
multiple interactions |
EXP |
1 |
130,683,155 |
130,884,752 |
RGD:6480464 |
CTD |
| G |
Sv2b |
synaptic vesicle glycoprotein 2b |
|
increases expression |
EXP |
1 |
130,683,155 |
130,884,752 |
RGD:6480464 |
CTD |
| G |
Syp |
synaptophysin |
|
multiple interactions |
EXP |
X |
26,890,307 |
26,905,319 |
RGD:6480464 |
CTD |
| G |
Syt11 |
synaptotagmin XI |
|
decreases expression |
EXP |
2 |
180,874,372 |
180,897,792 |
RGD:6480464 |
CTD |
| G |
Syt11 |
synaptotagmin XI |
|
multiple interactions |
EXP |
2 |
180,874,372 |
180,897,792 |
RGD:6480464 |
CTD |
| G |
Syt2 |
synaptotagmin II |
|
multiple interactions |
EXP |
13 |
47,690,518 |
47,699,094 |
RGD:6480464 |
CTD |
| G |
Syt4 |
synaptotagmin IV |
|
multiple interactions |
EXP |
18 |
23,805,080 |
23,814,489 |
RGD:6480464 |
CTD |
| G |
Tacr2 |
tachykinin receptor 2 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tap2 |
transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) |
|
multiple interactions |
EXP |
20 |
4,770,446 |
4,784,488 |
RGD:6480464 |
CTD |
| G |
Tbxa2r |
thromboxane A2 receptor |
|
multiple interactions |
EXP |
7 |
9,867,739 |
9,872,536 |
RGD:6480464 |
CTD |
| G |
Tfrc |
transferrin receptor |
|
multiple interactions |
EXP |
11 |
69,976,258 |
69,998,098 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
multiple interactions |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
decreases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tk1 |
thymidine kinase 1, soluble |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
multiple interactions |
EXP |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tpp2 |
tripeptidyl peptidase II |
|
multiple interactions |
EXP |
9 |
42,984,834 |
43,066,195 |
RGD:6480464 |
CTD |
| G |
Tuba1a |
tubulin, alpha 1A |
|
multiple interactions |
EXP |
7 |
137,729,405 |
137,733,071 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
decreases expression |
EXP |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
multiple interactions |
EXP |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Unc5b |
unc-5 homolog B (C. elegans) |
|
multiple interactions |
EXP |
20 |
28,095,243 |
28,162,204 |
RGD:6480464 |
CTD |
| G |
Vcp |
valosin-containing protein |
|
multiple interactions |
EXP |
5 |
59,472,100 |
59,491,508 |
RGD:6480464 |
CTD |
| G |
Vhl |
von Hippel-Lindau tumor suppressor, E3 ubiquitin protein ligase |
|
multiple interactions |
EXP |
4 |
149,529,396 |
149,536,289 |
RGD:6480464 |
CTD |
| G |
Vipr1 |
vasoactive intestinal peptide receptor 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Vipr2 |
vasoactive intestinal peptide receptor 2 |
|
multiple interactions |
EXP |
6 |
143,347,748 |
143,416,680 |
RGD:6480464 |
CTD |
| G |
Ywhae |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide |
|
multiple interactions |
EXP |
10 |
63,072,128 |
63,109,833 |
RGD:6480464 |
CTD |
| G |
Ywhag |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
|
multiple interactions |
EXP |
12 |
21,859,804 |
21,888,050 |
RGD:6480464 |
CTD |
| G |
Ywhag |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide |
|
increases expression |
EXP |
12 |
21,859,804 |
21,888,050 |
RGD:6480464 |
CTD |
| G |
Ywhah |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide |
|
multiple interactions |
EXP |
14 |
83,448,395 |
83,457,778 |
RGD:6480464 |
CTD |
| G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
|
increases expression |
EXP |
7 |
72,283,825 |
72,306,126 |
RGD:6480464 |
CTD |
| G |
Ywhaz |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide |
|
multiple interactions |
EXP |
7 |
72,283,825 |
72,306,126 |
RGD:6480464 |
CTD |
Term paths to the root
|